My Account

Partners

Pfizer s Arthritis Drug Xeljanz Gets Marketing Nod in Europe

Pfizer, Inc.’s PFE rheumatoid arthritis (RA) drug, Xeljanz has received marketing approval in Europe. The European Commission has approved Xeljanz (5 mg ...

Alexa Traffic


Listing Links